AgeX Therapeutics Financials
| AGEDelisted Stock | USD 0.74 0.01 1.37% |
AgeX |
Understanding current and past AgeX Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AgeX Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in AgeX Therapeutics' assets may result in an increase in income on the income statement.
Please note, the presentation of AgeX Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AgeX Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AgeX Therapeutics' management manipulating its earnings.
AgeX Therapeutics Stock Summary
AgeX Therapeutics competes with MAIA Biotechnology, Larimar Therapeutics, Lyra Therapeutics, Lineage Cell, and Cadrenal Therapeutics,. AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. AgeX Therapeutics, Inc. was incorporated in 2017 and is based in Alameda, California. Agex Therapeutics operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people.| Instrument | USA Stock View All |
| Exchange | NYSE MKT Exchange |
| ISIN | US00848H1086 |
| Business Address | 1101 Marina Village |
| New Symbol | SER |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.agexinc.com |
| Phone | 510 671 8370 |
| Currency | USD - US Dollar |
AgeX Therapeutics Key Financial Ratios
| Return On Asset | -0.82 | |||
| Beta | 1.19 | |||
| Z Score | -14.21 |
AgeX Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AgeX Therapeutics's current stock value. Our valuation model uses many indicators to compare AgeX Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AgeX Therapeutics competition to find correlations between indicators driving AgeX Therapeutics's intrinsic value. More Info.AgeX Therapeutics is rated below average in return on asset category among its peers. It is rated below average in operating margin category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value AgeX Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.AgeX Therapeutics Market Pulse
| Quote | 0.74 |
| Change(%) | 1.37 |
| Change | 0.01 |
| Open | 0.73 |
| Low | 0.72 |
| High | 0.76 |
| Volume | 0 |
| Exchange | NYSE MKT |
About AgeX Therapeutics Financials
What exactly are AgeX Therapeutics Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include AgeX Therapeutics' income statement, its balance sheet, and the statement of cash flows. Potential AgeX Therapeutics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although AgeX Therapeutics investors may use each financial statement separately, they are all related. The changes in AgeX Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AgeX Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.AgeX Therapeutics November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of AgeX Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of AgeX Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of AgeX Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing AgeX Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build AgeX Therapeutics's daily price indicators and compare them against related drivers.
| Downside Deviation | 6.27 | |||
| Information Ratio | 0.0635 | |||
| Maximum Drawdown | 47.55 | |||
| Value At Risk | (9.20) | |||
| Potential Upside | 8.2 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in AgeX Stock
If you are still planning to invest in AgeX Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AgeX Therapeutics' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |